FDA Approves First Treatment for MAS in Still Disease
The FDA has approved the interferon gamma-blocking antibody emapalumab-lzsg (Gamifant) for the treatment of macrophage activation syndrome (MAS)…
Startup Pi Health Built A Hospital In India To Test Its AI Software
New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built…
More Days, More Resistance: Time to Rethink Antibiotics
“One of the most universally accepted beliefs around the world,” said Brad Spellberg, MD, chief medical officer at…
GLP-1 drugs effective for type 1 diabetes in new study| STAT
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach…
Amgen obesity drug MariTide led to high discontinuation rates in trial
CHICAGO — Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects…
Study finds GLP-1 drug cut migraine frequency by nearly half
GLP-1 drugs could treat more than just diabetes and obesity. They may also reduce migraine frequency. That is…
Treatment that is tailored just for you – Life News
A new study, published in The New England Journal of Medicine in May this year, brought to light…